0001209191-21-065826.txt : 20211119
0001209191-21-065826.hdr.sgml : 20211119
20211119163852
ACCESSION NUMBER: 0001209191-21-065826
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20211117
FILED AS OF DATE: 20211119
DATE AS OF CHANGE: 20211119
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: TANG KEVIN C
CENTRAL INDEX KEY: 0001178579
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38318
FILM NUMBER: 211428851
MAIL ADDRESS:
STREET 1: 4747 EXECUTIVE DRIVE
STREET 2: SUITE 210
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: TANG CAPITAL PARTNERS LP
CENTRAL INDEX KEY: 0001191935
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38318
FILM NUMBER: 211428850
BUSINESS ADDRESS:
STREET 1: 4747 EXECUTIVE DRIVE
STREET 2: SUITE 210
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
BUSINESS PHONE: 858-200-3830
MAIL ADDRESS:
STREET 1: 4747 EXECUTIVE DRIVE
STREET 2: SUITE 210
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Hearne Michael S
CENTRAL INDEX KEY: 0001759910
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38318
FILM NUMBER: 211428848
MAIL ADDRESS:
STREET 1: 4747 EXECUTIVE DRIVE
STREET 2: SUITE 210
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: TANG CAPITAL MANAGEMENT LLC
CENTRAL INDEX KEY: 0001232621
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38318
FILM NUMBER: 211428849
BUSINESS ADDRESS:
STREET 1: 4747 EXECUTIVE DRIVE
STREET 2: SUITE 210
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
BUSINESS PHONE: 858-200-3830
MAIL ADDRESS:
STREET 1: 4747 EXECUTIVE DRIVE
STREET 2: SUITE 210
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Odonate Therapeutics, Inc.
CENTRAL INDEX KEY: 0001717452
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 822493065
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 3 EAST 28TH STREET
STREET 2: 10TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10016
BUSINESS PHONE: 332-206-0935
MAIL ADDRESS:
STREET 1: 3 EAST 28TH STREET
STREET 2: 10TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10016
FORMER COMPANY:
FORMER CONFORMED NAME: Odonate Therapeutics, Inc
DATE OF NAME CHANGE: 20171207
FORMER COMPANY:
FORMER CONFORMED NAME: Odonate Therapeutics, LLC
DATE OF NAME CHANGE: 20170919
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2021-11-17
0
0001717452
Odonate Therapeutics, Inc.
ODT
0001178579
TANG KEVIN C
4747 EXECUTIVE DRIVE
SUITE 210
SAN DIEGO
CA
92121
1
1
1
0
Chief Executive Officer
0001191935
TANG CAPITAL PARTNERS LP
4747 EXECUTIVE DRIVE
SUITE 210
SAN DIEGO
CA
92121
0
0
1
0
0001232621
TANG CAPITAL MANAGEMENT LLC
4747 EXECUTIVE DRIVE
SUITE 210
SAN DIEGO
CA
92121
0
0
1
0
0001759910
Hearne Michael S
4747 EXECUTIVE DRIVE
SUITE 210
SAN DIEGO
CA
92121
0
1
0
0
Chief Financial Officer
Common Stock
2021-11-17
4
S
0
468849
2.6583
D
15045717
I
By LP
Common Stock
2021-11-17
4
S
0
31151
1.9941
D
15014566
I
By LP
Common Stock
2021-11-17
4
S
0
500000
2.0161
D
14514566
I
By LP
Common Stock
2021-11-17
4
S
0
287577
2.1985
D
14226989
I
By LP
Common Stock
2021-11-18
4
S
0
212423
1.9708
D
14014566
I
By LP
Common Stock
2021-11-18
4
S
0
500000
1.8812
D
13514566
I
By LP
Common Stock
2021-11-18
4
S
0
381842
1.8925
D
13132724
I
By LP
Common Stock
2021-11-19
4
S
0
365289
1.9161
D
12767435
I
By LP
The prices reported in Column 4 are weighted-average prices. These shares were sold in multiple transactions at prices ranging from $2.01 to $3.01. The Reporting Persons undertake to provide the Issuer, any security holder of the Issuer or the SEC Staff, upon request, full information regarding the number of shares sold at each price within the ranges set forth in footnotes 1 and 3 through 9 herein.
The securities are beneficially owned by Tang Capital Partners, LP ("TCP"). Kevin Tang is the sole manager of Tang Capital Management,
LLC ("TCM"), which is the general partner of TCP. The shares reported as beneficially owned by TCP include a total of 154,285 shares of
common stock that are held of record by Odonate Holdings, LLC ("Holdings"). Holdings has granted a proxy to TCP giving TCP the sole authority
to vote such shares. Michael Hearne is the Chief Financial Officer of Odonate Therapeutics, Inc., as well as Chief Financial Officer of TCM. Mr. Tang and Mr. Hearne each have a pecuniary interest in a portion of the shares beneficially held by TCP.
The prices reported in Column 4 are weighted-average prices. These shares were sold in multiple transactions at prices ranging from $1.99 to $2.005.
The prices reported in Column 4 are weighted-average prices. These shares were sold in multiple transactions at prices ranging from $1.95 to $2.07.
The prices reported in Column 4 are weighted-average prices. These shares were sold in multiple transactions at prices ranging from $2.10 to $2.33.
The prices reported in Column 4 are weighted-average prices. These shares were sold in multiple transactions at prices ranging from $1.91 to $2.16.
The prices reported in Column 4 are weighted-average prices. These shares were sold in multiple transactions at prices ranging from $1.85 to $1.99.
The prices reported in Column 4 are weighted-average prices. These shares were sold in multiple transactions at prices ranging from $1.85 to $2.001.
The prices reported in Column 4 are weighted-average prices. These shares were sold in multiple transactions at prices ranging from $1.85 to $1.985.
/s/ Kevin Tang
2021-11-19
/s/ Kevin Tang, Managing Member of Tang Capital Management, LLC, General Partner
2021-11-19
/s/ Kevin Tang, Managing Member
2021-11-19
/s/ Michael Hearne
2021-11-19